[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3214083T3 - Fremgangsmåde til fremstilling af quinolonforbindelser - Google Patents

Fremgangsmåde til fremstilling af quinolonforbindelser Download PDF

Info

Publication number
DK3214083T3
DK3214083T3 DK17163383.7T DK17163383T DK3214083T3 DK 3214083 T3 DK3214083 T3 DK 3214083T3 DK 17163383 T DK17163383 T DK 17163383T DK 3214083 T3 DK3214083 T3 DK 3214083T3
Authority
DK
Denmark
Prior art keywords
quinolon
compounds
making
quinolon compounds
making quinolon
Prior art date
Application number
DK17163383.7T
Other languages
English (en)
Inventor
Roger Hanselmann
Maxwell M Reeve
Graham Johnson
Original Assignee
Melinta Subsidiary Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Subsidiary Corp filed Critical Melinta Subsidiary Corp
Application granted granted Critical
Publication of DK3214083T3 publication Critical patent/DK3214083T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H57/00General details of gearing
    • F16H57/02Gearboxes; Mounting gearing therein
    • F16H57/027Gearboxes; Mounting gearing therein characterised by means for venting gearboxes, e.g. air breathers
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H57/00General details of gearing
    • F16H57/02Gearboxes; Mounting gearing therein
    • F16H57/037Gearboxes for accommodating differential gearings
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H48/00Differential gearings
    • F16H48/06Differential gearings with gears having orbital motion
    • F16H48/08Differential gearings with gears having orbital motion comprising bevel gears
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H57/00General details of gearing
    • F16H57/04Features relating to lubrication or cooling or heating
    • F16H57/0457Splash lubrication
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H57/00General details of gearing
    • F16H57/04Features relating to lubrication or cooling or heating
    • F16H57/048Type of gearings to be lubricated, cooled or heated
    • F16H57/0482Gearings with gears having orbital motion
    • F16H57/0483Axle or inter-axle differentials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00Machine element or mechanism
    • Y10T74/19Gearing
    • Y10T74/19642Directly cooperating gears
    • Y10T74/19688Bevel
    • Y10T74/19693Motor vehicle drive
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00Machine element or mechanism
    • Y10T74/21Elements
    • Y10T74/2186Gear casings
    • Y10T74/2188Axle and torque tubes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
DK17163383.7T 2008-09-24 2009-09-23 Fremgangsmåde til fremstilling af quinolonforbindelser DK3214083T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19408308P 2008-09-24 2008-09-24
EP09816565.7A EP2346855B1 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds

Publications (1)

Publication Number Publication Date
DK3214083T3 true DK3214083T3 (da) 2020-12-07

Family

ID=42060333

Family Applications (2)

Application Number Title Priority Date Filing Date
DK09816565.7T DK2346855T3 (da) 2008-09-24 2009-09-23 Fremgangsmåde til fremstilling af quinolonsammensætninger
DK17163383.7T DK3214083T3 (da) 2008-09-24 2009-09-23 Fremgangsmåde til fremstilling af quinolonforbindelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK09816565.7T DK2346855T3 (da) 2008-09-24 2009-09-23 Fremgangsmåde til fremstilling af quinolonsammensætninger

Country Status (27)

Country Link
US (3) USRE46617E1 (da)
EP (3) EP2346855B1 (da)
JP (2) JP6013734B2 (da)
KR (3) KR20170039758A (da)
CN (2) CN102164912B (da)
AU (1) AU2009297085B2 (da)
BR (1) BRPI0919241B8 (da)
CA (1) CA2738236C (da)
CY (2) CY1123658T1 (da)
DK (2) DK2346855T3 (da)
ES (3) ES2826273T3 (da)
FI (1) FI3766876T3 (da)
HK (2) HK1214243A1 (da)
HR (1) HRP20201879T1 (da)
HU (2) HUE052219T2 (da)
IL (1) IL211845A (da)
LT (3) LT3766876T (da)
MX (2) MX2011003122A (da)
NL (1) NL301091I2 (da)
NO (1) NO2021006I1 (da)
PL (2) PL3214083T3 (da)
PT (1) PT3214083T (da)
RS (1) RS61194B1 (da)
RU (1) RU2546667C2 (da)
SG (1) SG10201605492YA (da)
SI (1) SI3214083T1 (da)
WO (1) WO2010036329A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576216B2 (en) * 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
EP2346855B1 (en) 2008-09-24 2017-04-05 Melinta Therapeutics, Inc. Process for making quinolone compounds
TW201444558A (zh) * 2013-03-15 2014-12-01 Melinta Therapeutics Inc 使用喹諾酮類抗生素治療淋病感染的方法
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
CN103709100A (zh) * 2013-12-31 2014-04-09 南京工业大学 一种8-氯代喹诺酮衍生物的制备方法
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
CN106256824B (zh) * 2015-06-18 2020-10-27 重庆医药工业研究院有限责任公司 一种高纯度德拉沙星葡甲胺盐的制备方法
CN105017224A (zh) * 2015-07-10 2015-11-04 扬子江药业集团有限公司 一种德拉沙星葡甲胺晶型的制备方法
CN107778293B (zh) * 2016-08-29 2023-06-16 鲁南制药集团股份有限公司 一种改进的德拉沙星的制备方法
RU2019130519A (ru) 2017-03-31 2021-04-30 Фуджифилм Корпорэйшн 4-пиридоновое соединение или его соль, фармацевтическая композиция и содержащий их состав
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
CN113527262B (zh) * 2021-06-22 2022-07-15 安徽普利药业有限公司 一种德拉沙星及其葡甲胺盐的精制方法
CN114031607B (zh) * 2021-11-16 2023-01-10 海南普利制药股份有限公司 一种德拉沙星及其中间体的精制方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
DE69623358T2 (de) 1995-09-22 2003-05-08 Wakunaga Pharma Co Ltd Pyridoncarbonsäurederivate als antibakterielle Wirkstoffe
NZ516201A (en) * 1999-07-01 2003-06-30 Wakunaga Pharamaceutical Co Quinolinecarboxylic acid derivative or salts thereof that have antimicrobial effect
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
CA2575148C (en) * 2004-07-30 2012-07-17 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
ES2901955T3 (es) 2004-10-08 2022-03-24 Abbvie Inc Sal meglumínica y formas cristalinas de la misma de un farmaco (delafloxacina)
US20060228411A1 (en) 2005-04-11 2006-10-12 Huailiang Wu Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
EP2346855B1 (en) 2008-09-24 2017-04-05 Melinta Therapeutics, Inc. Process for making quinolone compounds

Also Published As

Publication number Publication date
NL301091I1 (nl) 2021-02-10
CY1123658T1 (el) 2021-05-05
RS61194B1 (sr) 2021-01-29
RU2546667C2 (ru) 2015-04-10
AU2009297085B2 (en) 2015-07-09
HUE052219T2 (hu) 2021-04-28
JP6013734B2 (ja) 2016-10-25
US8871938B2 (en) 2014-10-28
EP3214083A1 (en) 2017-09-06
EP2346855A4 (en) 2012-07-04
MX2020009790A (es) 2020-10-12
LTC3214083I2 (lt) 2022-06-27
LTPA2021002I1 (lt) 2021-03-10
CY2021004I1 (el) 2021-05-05
KR20160116020A (ko) 2016-10-06
CY2021004I2 (el) 2021-05-05
KR20110091504A (ko) 2011-08-11
AU2009297085A1 (en) 2010-04-01
EP3766876B1 (en) 2023-09-13
ES2966093T3 (es) 2024-04-18
EP2346855B1 (en) 2017-04-05
LT3766876T (lt) 2023-12-11
MX2011003122A (es) 2011-07-20
CA2738236C (en) 2016-11-15
WO2010036329A2 (en) 2010-04-01
BRPI0919241A8 (pt) 2017-10-17
LT3214083T (lt) 2021-01-25
BRPI0919241B1 (pt) 2020-05-12
KR101775304B1 (ko) 2017-09-05
PT3214083T (pt) 2020-12-04
ES2826273T3 (es) 2021-05-17
BRPI0919241B8 (pt) 2021-05-25
WO2010036329A3 (en) 2010-07-01
EP3214083B1 (en) 2020-09-16
US20120041208A1 (en) 2012-02-16
CN102164912A (zh) 2011-08-24
USRE46617E1 (en) 2017-11-28
HRP20201879T1 (hr) 2021-01-22
SG10201605492YA (en) 2016-09-29
HUS2100004I1 (hu) 2021-03-01
DK2346855T3 (da) 2017-07-24
NO2021006I1 (no) 2021-02-15
BRPI0919241A2 (pt) 2016-06-21
JP2012508161A (ja) 2012-04-05
US20140171648A1 (en) 2014-06-19
HK1214243A1 (zh) 2016-07-22
IL211845A0 (en) 2011-06-30
CN105001207A (zh) 2015-10-28
EP3766876B8 (en) 2023-10-18
ES2629466T3 (es) 2017-08-09
RU2011116052A (ru) 2012-10-27
EP3766876A1 (en) 2021-01-20
EP2346855A2 (en) 2011-07-27
NL301091I2 (nl) 2021-08-03
PL3214083T3 (pl) 2021-04-06
FI3766876T3 (fi) 2023-12-05
KR20170039758A (ko) 2017-04-11
HK1244481A1 (zh) 2018-08-10
SI3214083T1 (sl) 2021-02-26
IL211845A (en) 2017-03-30
CA2738236A1 (en) 2010-04-01
CN102164912B (zh) 2015-08-19
PL3766876T3 (pl) 2024-04-02
JP2015178515A (ja) 2015-10-08
US8497378B2 (en) 2013-07-30

Similar Documents

Publication Publication Date Title
DK3214083T3 (da) Fremgangsmåde til fremstilling af quinolonforbindelser
DK2325648T3 (da) Fremgangsmåde til detektering af cancer
DK2204453T3 (da) Fremgangsmåde til celle-fri fremstilling af kemikalier
DK2262793T3 (da) Krystallinske former af nilotinib-hci
DK2310437T3 (da) Fremgangsmåde til kontinuerlig fremstilling af polyestere
DK2982690T3 (da) Fremgangsmåde til fremstilling af domæne-antistoffer
DK3329775T3 (da) Fremgangsmåder til syntese af diarylthiohydantoin- og diarylhydantoinforbindelser
DK2208469T3 (da) Fremgangsmåde til fremstilling af en ortopædisk skæreblok
DK2293816T3 (da) Fremgangsmåder til behandling af reumatoid arthritis
DK2513135T3 (da) Fremgangsmåde til oprensning af polypeptider
DK2126801T3 (da) Fremgangsmåde til udvælgelse af information
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
DK1884507T3 (da) Fremgangsmåde til fremstilling af glycerol
DK2282209T3 (da) Fremgangsmåde til markering af sukkerkæder
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2151427T3 (da) Ny fremgangsmåde til syntetisering af agomelatin
DK3106873T3 (da) Fremgangsmåde til detektering af cancer
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2311970T3 (da) Fremgangsmåde til fremstillingen af bioprodukter
DK2382232T3 (da) Fremgangsmåde til fremstilling af bivalirudin
DK2079577T3 (da) Fremgangsmåde til fremstilling af fodtøj
DK2021309T3 (da) Fremgangsmåde til fremstilling af methanol
DK2471983T3 (da) Fremgangsmåde til fremstilling af meta-aramidfibre
DK2554174T3 (da) Fremgangsmåde til behandling af sygdomme
DK2307441T3 (da) Fremgangsmåde til fremstilling af insulinforbindelser